Breaking News Instant updates and real-time market news.

2022-05-26 18:42:33 PDSB PDS Biotechnology $4.99 / -0.06 (-1.19%) 18:42 05/26/22 05/26 18:42 05/26/22 18:42	PDS Biotechnology announces presentation of Phase 2 data on PDS0101 at ASCO PDS Biotechnology "announced an upcoming poster presentation of preliminary data from its ongoing Phase 2 VERSATILE-002 clinical trial at the American Society of Clinical Oncology, ASCO, Annual Meeting taking place June 3-7, 2022 in Chicago and online. VERSATILE-002 is a single-arm Phase 2 study evaluating the safety and efficacy of PDS0101, an HPV16-targeted investigational T cell-activating immunotherapy that leverages PDS Biotech's proprietary Versamune technology, in combination with Merck's anti-PD-1 therapy KEYTRUDA. The combination is being evaluated in checkpoint inhibitor-naive and CPI-refractory patients with recurrent/metastatic HPV16-positive head and neck squamous cell carcinoma. The data being presented at ASCO will detail preliminary safety and efficacy data for CPI-naive patients at a prespecified interim analysis point. In the VERSATILE-002 clinical trial, patients are being treated with KEYTRUDA(R) 200 mg by IV infusion every three weeks, plus subcutaneous injection of PDS0101 for the first 4 treatment cycles and again on Cycle 12; KEYTRUDA treatment continues for up to 35 cycles, or until disease progression or demonstrated intolerance to therapy."	03 Jun 15 Jun 15 Jun

2022-05-26 18:42:33

PDSB

PDS Biotechnology

$4.99 / -0.06 (-1.19%)

18:42

05/26/22

05/26

18:42

05/26/22

18:42

PDS Biotechnology announces presentation of Phase 2 data on PDS0101 at ASCO

PDS Biotechnology "announced an upcoming poster presentation of preliminary data from its ongoing Phase 2 VERSATILE-002 clinical trial at the American Society of Clinical Oncology, ASCO, Annual Meeting taking place June 3-7, 2022 in Chicago and online. VERSATILE-002 is a single-arm Phase 2 study evaluating the safety and efficacy of PDS0101, an HPV16-targeted investigational T cell-activating immunotherapy that leverages PDS Biotech's proprietary Versamune technology, in combination with Merck's anti-PD-1 therapy KEYTRUDA. The combination is being evaluated in checkpoint inhibitor-naive and CPI-refractory patients with recurrent/metastatic HPV16-positive head and neck squamous cell carcinoma. The data being presented at ASCO will detail preliminary safety and efficacy data for CPI-naive patients at a prespecified interim analysis point. In the VERSATILE-002 clinical trial, patients are being treated with KEYTRUDA(R) 200 mg by IV infusion every three weeks, plus subcutaneous injection of PDS0101 for the first 4 treatment cycles and again on Cycle 12; KEYTRUDA treatment continues for up to 35 cycles, or until disease progression or demonstrated intolerance to therapy."

03
Jun
15
Jun

15
Jun

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Newpark Resources director buys $239.5K in common stock » 19:03 08/17/22 08/17 19:03 08/17/22 19:03 NR Newpark Resources $2.64 / -0.02 (-0.75%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News NR Newpark Resources $2.64 / -0.02 (-0.75%) 02/18/22 Newpark Resources enters cooperation agreement with BLR, adds member to board
Hot Stocks	CI&T acquires Transpire for A$16.4M » 19:01 08/17/22 08/17 19:01 08/17/22 19:01 CINT CI&T $13.90 / +0.12 (+0.87%) CI&T announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options CINT CI&T $13.90 / +0.12 (+0.87%) 08/16/22 CI&T acquires Transpire for $16.4M 06/01/22 CI&T acquires Box 1824, terms undisclosed 05/19/22 CI&T falls -10.9% 05/19/22 CI&T falls -14.6% CINT CI&T $13.90 / +0.12 (+0.87%) 07/20/22 JPMorgan CI&T price target lowered to $15 from $18 at JPMorgan 12/06/21 Fly Intel: Top five analyst initiations 12/06/21 BofA BofA starts 'IT services rare breed' CI&T with a Buy 12/06/21 Morgan Stanley Morgan Stanley starts CI&T at Overweight, sees shares trading at discount CINT CI&T $13.90 / +0.12 (+0.87%) 17:25 Today CI&T sees FY22 revenue growth of at least 55% on constant currency basis 17:23 Today 3CI&T sees Q3 net revenue up at least 46% from Q322 to R$540M 17:22 Today CI&T reports Q2 up 67% y-o-y to R$525.0M 05/18/22 CI&T raises FY22 net revenue view to $442M from $433M, consensus $431.4M 10 Nov CINT CI&T $13.90 / +0.12 (+0.87%) 05/19/22 Fly Intel: Pre-market Movers 05/18/22 Fly Intel: After-Hours Movers 08/18/22 CI&T - CINT CINT CI&T $13.90 / +0.12 (+0.87%) 05/25/22 new option listings and one option delisting on May 25th
Hot Stocks	NYSE to suspend trading in Eros Media World » 18:46 08/17/22 08/17 18:46 08/17/22 18:46 EMWP Eros Media World $1.61 / -0.05 (-3.01%) NYSE announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Initiation	Casey's General Stores initiated with an Outperform at Wolfe Research » 18:30 08/17/22 08/17 18:30 08/17/22 18:30 CASY Casey's General Stores $212.86 / -0.16 (-0.08%) Wolfe Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CASY Casey's General Stores $212.86 / -0.16 (-0.08%) 06/27/22 Casey's General Stores appoints Donthi to board of directors 06/07/22 Casey's General Stores sees FY23 same-store inside sales up 4%-6% 06/07/22 Casey's General Stores raises quarterly dividend 9% to 38c per share 04/21/22 Casey's General Stores provides business update ahead of NDR CASY Casey's General Stores $212.86 / -0.16 (-0.08%) 07/18/22 Benchmark Benchmark starts Casey's General Stores at Buy, cites proven growth model 07/18/22 Benchmark Casey's General Stores initiated with a Buy at Benchmark 06/22/22 Deutsche Bank Casey's General Stores price target lowered to $255 from $259 at Deutsche Bank 06/08/22 RBC Capital Casey's General Stores price target lowered to $238 from $250 at RBC Capital CASY Casey's General Stores $212.86 / -0.16 (-0.08%) 06/07/22 Casey's General Stores reports Q4 EPS $1.60, consensus $1.59 03/08/22 Casey's General Stores reports Q3 EPS $1.71, consensus $1.45 CASY Casey's General Stores $212.86 / -0.16 (-0.08%) 05/25/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/19/22 Groceryshop 09/08/22 Casey's General Stores - CASY 08/30/22 Casey's General Stores Inc.
Periodicals	WWE board finds former CEO McMahon gave $5M to Trump charity, WSJ says » 18:25 08/17/22 08/17 18:25 08/17/22 18:25 WWE WWE $71.86 / -1.41 (-1.92%) An internal board… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events WWE WWE $71.86 / -1.41 (-1.92%) 08/16/22 WWE announces record first-day ticket sales for WrestleMania 39 08/16/22 WWE raises FY22 adjusted OIBDA view to $370M-$385M from $360M-$375M 08/16/22 WWE sees Q3 adjusted OIBDA $70M-$80M 08/16/22 WWE: Probe of Vince McMahon 'substantially complete' WWE WWE $71.86 / -1.41 (-1.92%) 06:48 Today Benchmark WWE price target raised to $83 from $80 at Benchmark 06:25 Today Barclays Barclays ups WWE target but says company sale unlikely 07/26/22 Benchmark WWE price target raised to $80 from $71 at Benchmark 07/25/22 Loop Capital Loop Capital upgrades WWE to Buy on rising likelihood of company sale WWE WWE $71.86 / -1.41 (-1.92%) 08/16/22 WWE reports Q2 adjusted EPS 59c vs. 34c last year 07/25/22 WWE reports preliminary Q2 revenue $328M, consensus $311.84M 05/05/22 WWE sees Q2 adjusted OIBDA $80M-$90M 05/05/22 WWE reports Q1 EPS 77c, consensus 61c WWE WWE $71.86 / -1.41 (-1.92%) 07/08/22 WWE's Vince McMahon paid over $12M to suppress misconduct claims, WSJ says 07/01/22 WWE signs multi-event agreement with Logan Paul, ESPN reports 06/15/22 WWE board investigating $3M 'hush pact' settlement by CEO, WSJ says 04/07/22 Formula 1, WWE could be acquisition targets for streaming companies, CNBC says WWE WWE $71.86 / -1.41 (-1.92%) 08/16/22 What You Missed On Wall Street On Tuesday 08/16/22 What You Missed On Wall Street This Morning 07/25/22 What You Missed On Wall Street On Monday 07/25/22 What You Missed On Wall Street This Morning 09/08/22 Consumer/Media/Entertainment Conference
Earnings	America's Car-Mart reports Q1 EPS $2.00, consensus $3.14 » 18:20 08/17/22 08/17 18:20 08/17/22 18:20 CRMT America's Car-Mart $119.28 / -6.68 (-5.30%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CRMT America's Car-Mart $119.28 / -6.68 (-5.30%) 03/16/22 America's Car-Mart appoints Brian Stone as EVP, procurement, inventory CRMT America's Car-Mart $119.28 / -6.68 (-5.30%) 04/06/22 BofA America's Car-Mart double-downgraded to Underperform at BofA 04/06/22 BofA America's Car-Mart downgraded to Underperform from Buy at BofA CRMT America's Car-Mart $119.28 / -6.68 (-5.30%) 05/23/22 America's Car-Mart reports Q4 EPS $4.01, consensus $3.10 CRMT America's Car-Mart $119.28 / -6.68 (-5.30%) 04/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/18/22 America's Car-Mart - CRMT 08/30/22 America's Car Mart Inc.
On The Fly	Fly Intel: After-Hours Movers » 18:16 08/17/22 08/17 18:16 08/17/22 18:16 WOLF Wolfspeed $85.58 / -3.08 (-3.47%) , CSCO Cisco $46.69 / -0.09 (-0.19%) , KEYS Keysight Technologies $169.27 / -1.45 (-0.85%) , SNPS Synopsys $380.78 / -4.86 (-1.26%) , BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) , DCP DCP Midstream $34.75 / -1.275 (-3.54%) , BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) , AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) , QUIK QuickLogic $7.64 / -0.46 (-5.68%) , BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) , GME GameStop $40.58 / -1.57 (-3.72%) , APRN Blue Apron $5.70 / +0.315 (+5.85%) , FUBO FuboTV $5.36 / -1.005 (-15.80%) , AMC AMC Entertainment $21.36 / -3.45 (-13.91%) … Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WOLF CSCO KEYS SNPS BLUE DCP BBWI AXDX QUIK BBBY GME APRN FUBO AMC WOLF Wolfspeed $85.58 / -3.08 (-3.47%) 16:14 Today Wolfspeed sees 2026 revenue outlook up 30%-40% from prior forecast 16:09 Today Wolfspeed jumps 12% to $95.59 after above-consensus Q4 earnings and guidance 05/09/22 Wolfspeed, Rhombus Energy collaborate for faster EV charging infrastructure 04/25/22 Wolfspeed says Lucid integrates Silicon Carbide solutions into Lucid Air CSCO Cisco $46.69 / -0.09 (-0.19%) 17:24 Today Cisco expects continued high levels of order backlog 16:46 Today Cisco says cancellations below pre-pandemic levels 16:09 Today Cisco sees Q1 adjusted gross margin 63%-64% 16:08 Today Cisco CEO says full year product orders, backlog at 'record highs' KEYS Keysight Technologies $169.27 / -1.45 (-0.85%) 08/15/22 Keysight Technologies extends collaboration with Synopsys 08/03/22 Keysight, Nokia collaborate on public 800GE test 07/29/22 The Digital IF Interoperability Consortium announces seven new members 07/13/22 AI-LINK selects Keysight's 5G test tools for performance validation SNPS Synopsys $380.78 / -4.86 (-1.26%) 08/15/22 Keysight Technologies extends collaboration with Synopsys 06/22/22 Synopsys sees WhiteHat Security acquisition neutral to FY22 adjusted EPS 05/27/22 Synopsys initiates $200M ASR with Wells Fargo 05/24/22 Synopsys enters distribution agreement with Arrow Electronics BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 14:37 Today Bluebird Bio confirms Zynteglo wholesale acquisition cost of $2.8M 14:30 Today Bluebird Bio trading resumes 14:12 Today Bluebird Bio to resume trading at 2:30 pm ET 14:08 Today Bluebird Bio confirms FDA approval of Zynteglo DCP DCP Midstream $34.75 / -1.275 (-3.54%) 17:09 Today Phillips 66 proposing consideration of $34.75 per unit of DCP Midstream 17:05 Today Phillips 66 increases interest in DCP Midstream from 28.26% to 43.31% 08/01/22 DCP Midstream releases annual Sustainability Report 07/19/22 DCP Midstream raises Q2 cash distribution 10% to 43c per unit BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) 16:25 Today Bath & Body Works saw declines in traffic trends in June, first part of July 16:24 Today Bath & Body Works recently cut 130 roles in home office organization 05/19/22 Bath & Body Works sees FY inflation impact $225M-$250M 05/19/22 Bath & Body Works to test new personal care line, including face and hair care AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 07/11/22 Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc 05/16/22 Accelerate Diagnostics begins commercialization of Accelerate Arc system 04/25/22 Accelerate Diagnostics' Arc System kit shows sample accuracy in studies QUIK QuickLogic $7.64 / -0.46 (-5.68%) 06/01/22 QuickLogic awarded new $3.0M eFPGA contract 03/30/22 QuickLogic wins new $1.5M eFPGA contract 03/10/22 QuickLogic wins new eFPGA contract for approximately $1M BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 16:59 Today Meme stocks slip afterhours as Ryan Cohen files intent to cash out of BBBY 16:44 Today RC Ventures files to sell Bed Bath & Beyond stake 10:03 Today Bed Bath & Beyond trading resumes 09:58 Today Bed Bath & Beyond trading halted, volatility trading pause GME GameStop $40.58 / -1.57 (-3.72%) 16:59 Today Meme stocks slip afterhours as Ryan Cohen files intent to cash out of BBBY 08/16/22 GameStop trading resumes 08/16/22 GameStop trading halted, volatility trading pause 08/08/22 GameStop trading resumes APRN Blue Apron $5.70 / +0.315 (+5.85%) 16:59 Today Meme stocks slip afterhours as Ryan Cohen files intent to cash out of BBBY 10:00 Today Blue Apron rises 10.6% 09:47 Today Blue Apron rises 22.5% 08:51 Today Blue Apron up 24% at $6.67 in pre-market trading FUBO FuboTV $5.36 / -1.005 (-15.80%) 16:59 Today Meme stocks slip afterhours as Ryan Cohen files intent to cash out of BBBY 08/16/22 FuboTV rises 20.1% 08/11/22 FuboTV adds SportsGrid network 08/08/22 FuboTV rises 14.1% AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 17:20 Today Cineworld evaluates strategic options amid slow attendance, limited film slate 08/08/22 AMC Entertainment rises 16.9% 08/08/22 AMC Entertainment trading resumes 08/08/22 AMC Entertainment trading halted, volatility trading pause WOLF CSCO KEYS SNPS BLUE DCP BBWI AXDX QUIK BBBY GME APRN FUBO AMC WOLF Wolfspeed $85.58 / -3.08 (-3.47%) 08/15/22 Piper Sandler ON Semiconductor price target raised to $90 from $75 at Piper Sandler 07/14/22 JPMorgan Wolfspeed price target lowered to $80 from $105 at JPMorgan 06/29/22 BofA Wolfspeed price target lowered to $75 from $95 at BofA 06/23/22 Goldman Sachs Wolfspeed upgraded to Buy from Neutral at Goldman Sachs CSCO Cisco $46.69 / -0.09 (-0.19%) 08/15/22 Citi Cisco to trade lower due to valuation multiple compression, says Citi 08/02/22 Citi Arista Networks price target raised to $170 from $160 at Citi 07/15/22 KGI Securities Cisco downgraded to Neutral from Outperform at KGI Securities 07/14/22 JPMorgan Cisco downgraded to Neutral from Overweight at JPMorgan KEYS Keysight Technologies $169.27 / -1.45 (-0.85%) 08/09/22 Deutsche Bank Keysight Technologies price target raised to $190 from $176 at Deutsche Bank 07/14/22 JPMorgan Keysight Technologies price target lowered to $176 from $200 at JPMorgan 06/17/22 UBS Keysight Technologies price target lowered to $177 from $220 at UBS 06/01/22 Goldman Sachs Keysight Technologies price target lowered to $165 from $185 at Goldman Sachs SNPS Synopsys $380.78 / -4.86 (-1.26%) 08/16/22 Wolfe Research Synopsys initiated with an Outperform at Wolfe Research 08/11/22 Wells Fargo Synopsys price target raised to $425 from $375 at Wells Fargo 06/29/22 BofA Synopsys upgraded to Neutral from Underperform at BofA 05/19/22 Needham Synopsys price target raised to $380 from $370 at Needham BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 15:37 Today BTIG Bluebird's approval has positive read for Mustang Bio, says BTIG 15:35 Today Piper Sandler Piper says FDA nod for Bluebird's beta-cel positive for Crispr's exa-cel 08/05/22 Barclays Barclays upgrades Bluebird Bio to Equal Weight, raises price target to $5 08/05/22 Barclays Bluebird Bio upgraded to Equal Weight from Underweight at Barclays DCP DCP Midstream $34.75 / -1.275 (-3.54%) 08/16/22 Barclays DCP Midstream price target raised to $40 from $38 at Barclays 07/20/22 Barclays DCP Midstream price target lowered to $38 from $43 at Barclays 07/12/22 RBC Capital DCP Midstream upgraded to Outperform from Sector Perform at RBC Capital 06/13/22 Raymond James DCP Midstream added to Analyst Current Favorites list at Raymond James BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) 08/16/22 B. Riley Bath & Body Works price target raised to $48 from $44 at B. Riley 07/25/22 Barclays Bath & Body Works price target lowered to $33 from $40 at Barclays 07/21/22 Deutsche Bank Bath & Body Works price target lowered to $41 from $61 at Deutsche Bank 07/21/22 B. Riley Bath & Body risk/reward attractive despite guidance cut, says B. Riley AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 03/09/22 Craig-Hallum Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5 03/09/22 Craig-Hallum Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum 01/14/22 Craig-Hallum Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum QUIK QuickLogic $7.64 / -0.46 (-5.68%) 11/18/21 Roth Capital QuickLogic price target raised to $12 from $8 at Roth Capital BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 08/16/22 Odeon Capital Odeon Capital downgrades Bed Bath & Beyond to Sell with $7.50 price target 08/16/22 Odeon Capital Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital 08/16/22 B. Riley B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell 08/16/22 B. Riley Bed Bath & Beyond downgraded to Sell from Neutral at B. Riley GME GameStop $40.58 / -1.57 (-3.72%) 08/16/22 B. Riley B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell 07/22/22 Wedbush GameStop price target lowered to $7.50 from $30 at Wedbush 05/26/22 Wedbush Wedbush keeps Underperform on GameStop citing valuation and cash burn concerns 03/28/22 B. Riley Bed Bath & Beyond price target raised to $26 from $19 at B. Riley APRN Blue Apron $5.70 / +0.315 (+5.85%) 08/10/22 Lake Street Blue Apron initiated with a Buy at Lake Street 07/20/22 Benchmark Benchmark starts Blue Apron at Buy with turnaround not getting credit 07/20/22 Benchmark Blue Apron initiated with a Buy at Benchmark 05/10/22 Canaccord Blue Apron price target lowered to $10 from $12 at Canaccord FUBO FuboTV $5.36 / -1.005 (-15.80%) 08:22 Today Evercore ISI FuboTV price target raised to $8 from $5 at Evercore ISI 07:56 Today Stephens Stephens sees no major news from FuboTV analyst day to justify 'short squeeze' 06:51 Today Wedbush Wedbush downgrades FuboTV to Neutral, raises price target to $6 06:16 Today Wedbush FuboTV downgraded to Neutral from Outperform at Wedbush AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/16/22 B. Riley B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell 07/07/22 Citi AMC Entertainment price target lowered to $5 from $6 at Citi 06/21/22 B. Riley AMC Entertainment price target lowered to $11 from $16 at B. Riley 06/06/22 Citi AMC Entertainment shares remain overvalued, says Citi WOLF CSCO KEYS SNPS BLUE DCP BBWI AXDX QUIK BBBY GME APRN FUBO AMC WOLF Wolfspeed $85.58 / -3.08 (-3.47%) 16:07 Today Wolfspeed sees Q1 EPS (8c) to (2c), consensus (7c) 16:06 Today Wolfspeed reports Q4 EPS (2c), consensus (10c) 05/04/22 Wolfspeed sees Q4 adjusted EPS (13c)-(7c), consensus (12c) 05/04/22 Wolfspeed reports Q3 adjusted EPS (12c), consensus (14c) CSCO Cisco $46.69 / -0.09 (-0.19%) 16:07 Today Cisco sees FY23 adjusted EPS $3.49-$3.56, consensus $3.53 16:06 Today Cisco sees Q1 adjusted EPS 82c-84c, consensus 84c 16:05 Today Cisco reports Q4 adjusted EPS 83c, consensus 82c 13:20 Today Notable companies reporting after market close KEYS Keysight Technologies $169.27 / -1.45 (-0.85%) 16:06 Today Keysight Technologies sees Q4 adjusted EPS $1.94-$2.00, consensus $1.89 16:06 Today Keysight Technologies reports Q3 adjusted EPS $2.01, consensus $1.78 05/17/22 Keysight Technologies sees FY22 EPS up 14%-15%, consensus $7.01 05/17/22 Keysight Technologies sees Q3 EPS $1.74-$1.80, consensus $1.75 SNPS Synopsys $380.78 / -4.86 (-1.26%) 16:12 Today Synopsys sees Q4 non-GAAP EPS $1.06-$1.18, consensus $1.73 16:11 Today Synopsys raises FY22 non-GAAP EPS view to $8.80-$8.85 from $7.85-$7.92 16:07 Today Synopsys reports Q3 non-GAAP EPS $2.10 vs $1.81 a year ago 13:20 Today Notable companies reporting after market close BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 08/04/22 Bluebird Bio reports Q2 EPS ($1.36), consensus ($1.24) 05/09/22 Bluebird Bio reports Q1 EPS ($1.66), consensus ($1.39) 03/04/22 Bluebird Bio reports Q4 EPS ($2.14), consensus ($1.88) DCP DCP Midstream $34.75 / -1.275 (-3.54%) 08/02/22 DCP Midstream reports Q2 EPS $1.77, consensus $1.13 05/04/22 DCP Midstream reports Q1 EPS 32c, may not compare to consensus 99c BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) 16:28 Today Bath & Body Works sees FY revenue down mid to high single digits vs. last year 16:26 Today Bath & Body Works sees Q3 sales down mid to high single digits vs. last year 16:21 Today Bath & Body Works sees FY22 EPS $2.70-$3.00, consensus $2.92 16:18 Today Bath & Body Works sees Q3 EPS 10c-20c, consensus 31c AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 05/16/22 Accelerate Diagnostics reports Q1 EPS (21c), consensus (30c) 03/08/22 Accelerate Diagnostics reports Q4 adjusted EPS (23c), consensus (25c) QUIK QuickLogic $7.64 / -0.46 (-5.68%) 08/16/22 QuickLogic reports Q2 non-GAAP EPS 0c, consensus (4c) 06/01/22 QuickLogic backs Q2 revenue view $4.5M, consensus $4.47M 05/17/22 QuickLogic reports Q1 adjusted EPS (6c), consensus (7c) BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 06/29/22 Bed Bath & Beyond reports Q1 adjusted EPS ($2.83), consensus ($1.39) 06/28/22 Notable companies reporting before tomorrow's open 06/28/22 Notable companies reporting before tomorrow's open 04/13/22 Bed Bath & Beyond reports Q4 adjusted EPS (92c), consensus 3c GME GameStop $40.58 / -1.57 (-3.72%) 06/01/22 GameStop reports Q1 EPS ($2.08), consensus ($1.45) 06/01/22 Notable companies reporting after market close 03/17/22 GameStop reports Q4 EPS ($1.94) vs $1.19 last year 03/17/22 Notable companies reporting after market close APRN Blue Apron $5.70 / +0.315 (+5.85%) 08/08/22 Blue Apron cuts FY22 revenue growth view to 7%-13% vs. mid-teens 08/08/22 Blue Apron reports Q2 EPS (68c) vs. (98c) a year ago 05/10/22 Blue Apron targets revenue of $700M-plus in 2024 05/09/22 Blue Apron sees FY revenue growth in mid teens, one est. $532.3M FUBO FuboTV $5.36 / -1.005 (-15.80%) 08/04/22 FuboTV reports Q2 EPS (45c), consensus (69c) 05/05/22 FuboTV reports Q1 EPS (69c), consensus (65c) 05/05/22 Notable companies reporting after market close 02/23/22 FuboTV reports Q4 EPS (57c), consensus (67c) AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/04/22 AMC Entertainment reports Q2 adjusted EPS (20c), consensus (19c) 05/09/22 AMC Entertainment reports Q1 adjusted EPS (52c), consensus (63c) 05/09/22 Notable companies reporting after market close 05/05/22 Hycroft Mining reports Q1 EPS (27c) vs. (16c) last year CSCO SNPS BLUE BBBY GME APRN AMC CSCO Cisco $46.69 / -0.09 (-0.19%) 06/23/22 Cisco, Nike planning to fully exit Russia, Reuters reports 06/23/22 Cisco to begin 'orderly wind-down' of Russia business, Reuters reports 06/06/22 CFOs send letter to Treasury Secretary on foreign tax credit rules, WSJ reports SNPS Synopsys $380.78 / -4.86 (-1.26%) 04/13/22 Synopsys probed by Commerce Department over China, Bloomberg reports 04/13/22 Synopsys sent subpoena from Commerce Department on China, Blomberg says BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 13:55 Today Bluebird Bio to charge $2.8M for Zynteglo treatment, Bloomberg says 06/10/22 FDA votes 13-0 in support of Bluebird Bio's Beti-Cel, Bloomberg reports 06/09/22 FDA panel: Bluebird Bio's Eli-Cel benefits outweigh risks, BioPharmaDrive says BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 16:35 Today RC Ventures files to sell entire Bed Bath & Beyond stake, Bloomberg says 08/13/22 Royal Caribbean among companies at risk of liquidity squeeze, Barron's says 08/03/22 Bed Bath & Beyond weighing private loans, Bloomberg reports 08/03/22 Bed Bath & Beyond in talks with private credit providers, Bloomberg says GME GameStop $40.58 / -1.57 (-3.72%) 08/13/22 Coinbase looking more like a meme stock, Barron's says 07/21/22 Europe game sales rose 13.5% year-over-year in 1H22, Gamesindustry.biz says 07/07/22 GameStop CFO Mike Recupero replaced by Diana Jajeh, Axios says 07/07/22 GameStop CFO out, company making layoffs, Axios says APRN Blue Apron $5.70 / +0.315 (+5.85%) 05/10/22 Blue Apron shares going to $10 unless management 'sociopaths,' Citrons says AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/15/22 Summer movies show audiences, studio chiefs committed to theaters, WSJ reports 08/13/22 Coinbase looking more like a meme stock, Barron's says 07/11/22 U.S. box office sales rising closer to pre-pandemic levels, CNBC reports WOLF CSCO KEYS SNPS BLUE BBWI QUIK BBBY GME APRN FUBO AMC WOLF Wolfspeed $85.58 / -3.08 (-3.47%) 07/22/22 Sell these stocks now, proven algorithm says 07/15/22 Sell these stocks now, proven algorithm says 07/08/22 Sell these stocks now, proven algorithm says 06/24/22 What You Missed On Wall Street On Friday CSCO Cisco $46.69 / -0.09 (-0.19%) 12:15 Today Here's what Wall Street experts are saying about Cisco ahead of earnings 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 05/19/22 What You Missed On Wall Street On Thursday KEYS Keysight Technologies $169.27 / -1.45 (-0.85%) 03/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SNPS Synopsys $380.78 / -4.86 (-1.26%) 05/19/22 Fly Intel: Pre-market Movers 05/18/22 Fly Intel: After-Hours Movers 04/13/22 What You Missed On Wall Street On Wednesday BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 16:24 Today What You Missed On Wall Street On Wednesday 08/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/13/22 What You Missed On Wall Street On Monday 06/13/22 Fly Intel: Pre-market Movers BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) 07/20/22 What You Missed On Wall Street On Wednesday 07/20/22 What You Missed On Wall Street This Morning 07/20/22 Fly Intel: Pre-market Movers 06/30/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations QUIK QuickLogic $7.64 / -0.46 (-5.68%) 05/17/22 Fly Intel: After-Hours Movers BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 08/16/22 Fly Intel: After-Hours Movers 08/16/22 What You Missed On Wall Street On Tuesday 08/16/22 What You Missed On Wall Street This Morning 08/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations GME GameStop $40.58 / -1.57 (-3.72%) 08/12/22 Short Report: Bed Bath Beyond shorts nudge higher as stock soars 08/09/22 What You Missed This Week in Video Games 08/06/22 Opening Day: Magic Empire opening surge calls to mind AMTD Digital frenzy 08/03/22 Citron says AMTD Digital ‘NOT a meme stock’ despite massive rise in shares APRN Blue Apron $5.70 / +0.315 (+5.85%) 08/12/22 Short Report: Bed Bath Beyond shorts nudge higher as stock soars 08/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/04/22 Short Report: GameStop short position reaches 15-month high 06/01/22 Fly Intel: After-Hours Movers FUBO FuboTV $5.36 / -1.005 (-15.80%) 12:03 Today What You Missed On Wall Street This Morning 09:59 Today Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/12/22 Bet On It: Massachusetts betting bill signed into law ahead of NFL season 05/13/22 Short Report: Upstart shorts take profits as stock craters on guidance cut AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/15/22 What You Missed On Wall Street This Morning 08/05/22 Fly Intel: Pre-market Movers 08/04/22 Fly Intel: After-Hours Movers 07/15/22 Sell these stocks now, proven algorithm says 00:00 Today August Virtual Micro Cap Conference 16:30 Today Cisco - CSCO 16:30 Today Keysight Technologies - KEYS 17:00 Today Synopsys - SNPS 17:00 Today Wolfspeed - WOLF 08/18/22 Bath & Body Works - BBWI 09/23/22 Wolfspeed - WOLF 08/19/22 PDUFA Date for betibeglogene autotemcel (beti-cel) 09/16/22 PDUFA Date for Elivaldogene Autotemcel (Eli-cel, Lenti-D) WOLF CSCO SNPS BLUE BBWI BBBY GME APRN FUBO AMC WOLF Wolfspeed $85.58 / -3.08 (-3.47%) 13:49 Today Wolfspeed options imply 9.5% move in share price post-earnings CSCO Cisco $46.69 / -0.09 (-0.19%) 13:04 Today Cisco options imply 4.7% move in share price post-earnings 06/28/22 Cisco put volume heavy and directionally bearish 06/10/22 Cisco put volume heavy and directionally bearish 05/20/22 Notable open interest changes for May 20th SNPS Synopsys $380.78 / -4.86 (-1.26%) 14:04 Today Synopsys options imply 4.0% move in share price post-earnings 05/19/22 Early notable gainers among liquid option names on May 19th BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 08/12/22 Bluebird Bio call volume above normal and directionally bullish 08/11/22 Bluebird Bio call volume above normal and directionally bullish 08/08/22 Bluebird Bio call volume above normal and directionally bullish 08/05/22 Bluebird Bio call volume above normal and directionally bullish BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) 13:19 Today Bath & Body Works options imply 7.3% move in share price post-earnings 08/16/22 Early notable gainers among liquid option names on August 16th 07/20/22 Bath & Body Works put volume heavy and directionally bearish 07/06/22 Bath & Body Works put volume heavy and directionally bearish BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 08:55 Today Notable open interest changes for August 17th 08/16/22 Bed Bath & Beyond call volume above normal and directionally bullish 08/16/22 Notable open interest changes for August 16th 08/15/22 Unusually active option classes on open August 15th GME GameStop $40.58 / -1.57 (-3.72%) 08/16/22 GameStop call volume above normal and directionally bullish 08/08/22 GameStop call volume above normal and directionally bullish 07/25/22 Notable open interest changes for July 25th 07/22/22 Unusually active option classes on open July 22nd APRN Blue Apron $5.70 / +0.315 (+5.85%) 09:40 Today Unusually active option classes on open August 17th 08/16/22 Blue Apron call volume above normal and directionally bullish 08/15/22 Unusually active option classes on open August 15th 07/07/22 Largest borrow rate increases among liquid names FUBO FuboTV $5.36 / -1.005 (-15.80%) 08:55 Today Notable open interest changes for August 17th 08/16/22 fuboTV call volume above normal and directionally bullish 08/03/22 Unusually active option classes on open August 3rd 07/15/22 Largest borrow rate increases among liquid names AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/09/22 Notable open interest changes for August 9th 08/08/22 Notable open interest changes for August 8th 08/05/22 Notable open interest changes for August 5th 08/04/22 AMC Entertainment options imply 11.7% move in share price post-earnings
Syndicate	Accelerate Diagnostics announces common stock offering, no amount given » 18:01 08/17/22 08/17 18:01 08/17/22 18:01 AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) Accelerate Diagnostics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 07/11/22 Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc 05/16/22 Accelerate Diagnostics begins commercialization of Accelerate Arc system 04/25/22 Accelerate Diagnostics' Arc System kit shows sample accuracy in studies AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 03/09/22 Craig-Hallum Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5 03/09/22 Craig-Hallum Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum 01/14/22 Craig-Hallum Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 05/16/22 Accelerate Diagnostics reports Q1 EPS (21c), consensus (30c) 03/08/22 Accelerate Diagnostics reports Q4 adjusted EPS (23c), consensus (25c)
Hot Stocks	SeaChange promotes Chris Klimmer to President » 17:56 08/17/22 08/17 17:56 08/17/22 17:56 SEAC SeaChange / + SeaChange International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly SEAC SeaChange / + 07/15/22 SeaChange chairman Robert Pons resigns, Peter Aquino named chairman 06/14/22 Trillerverz, SeaChange agree to mutually terminate proposed merger 06/14/22 SeaChange, Triller mutually agree to terminate proposed merger agreement 04/04/22 SeaChange, VIDAA partner to develop streaming, ad insertion solution SEAC SeaChange / + 04/08/22 SeaChange reports Q4 adjusted EPS 2c vs. (9c) last year SEAC SeaChange / + 07/30/22 Opening Day: Immune-oncology company MAIA Biotechnology drops in market debut 07/16/22 Opening Day: AMTD Digital soars in trading debut 07/02/22 Opening Day: Ivanhoe Electric falls in debut after raising $169M in IPO
Hot Stocks	Vertex Pharmaceuticals CEO sells $3.6M in common stock » 17:52 08/17/22 08/17 17:52 08/17/22 17:52 VRTX Vertex Pharmaceuticals $299.17 / -3.88 (-1.28%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options VRTX Vertex Pharmaceuticals $299.17 / -3.88 (-1.28%) 08/04/22 Vertex Pharmaceuticals raises FY22 product revenue view to $8.6B-$8.8B 07/22/22 Vertex Pharmaceuticals plans to advance VX-548 into Phase 3 clinical trials 07/20/22 Vertex Pharmaceuticals, Verve Therapeutics enter exclusive research pact 07/11/22 Vertex Pharmaceuticals to acquire ViaCyte for $320M in cash VRTX Vertex Pharmaceuticals $299.17 / -3.88 (-1.28%) 15:35 Today Piper Sandler Piper says FDA nod for Bluebird's beta-cel positive for Crispr's exa-cel 08/16/22 Piper Sandler Vertex Pharmaceuticals price target raised to $288 from $256 at Piper Sandler 08/05/22 Truist Global Blood could complement any oncology franchise, says Truist 08/05/22 H.C. Wainwright Vertex Pharmaceuticals price target raised to $300 from $275 at H.C. Wainwright VRTX Vertex Pharmaceuticals $299.17 / -3.88 (-1.28%) 08/04/22 Vertex Pharmaceuticals reports Q2 adjusted EPS $3.60, consensus $3.48 05/05/22 Vertex Pharmaceuticals reports Q1 adjusted EPS $3.52, consensus $3.49 05/05/22 Notable companies reporting after market close VRTX Vertex Pharmaceuticals $299.17 / -3.88 (-1.28%) 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 06/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations VRTX Vertex Pharmaceuticals $299.17 / -3.88 (-1.28%) 07/05/22 Early notable gainers among liquid option names on July 5th

Hot Stocks	Orchid Island Capital announces 1-for-5 reverse stock split » 17:50 08/17/22 08/17 17:50 08/17/22 17:50 ORC Orchid Island Capital $3.21 / -0.04 (-1.23%) Orchid Island Capital… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ORC Orchid Island Capital $3.21 / -0.04 (-1.23%) 04/13/22 Orchid Island Capital estimates book value per share of $3.34 as of March 31 ORC Orchid Island Capital $3.21 / -0.04 (-1.23%) 08/08/22 Ladenburg Orchid Island downgraded on expected dividend cut at Ladenburg 08/08/22 Ladenburg Orchid Island Capital downgraded to Neutral from Buy at Ladenburg 02/25/22 JonesTrading Orchid Island downgraded on book value drop-off at JonesTrading 02/25/22 JonesTrading Orchid Island Capital downgraded to Hold from Buy at JonesTrading ORC Orchid Island Capital $3.21 / -0.04 (-1.23%) 07/13/22 Orchid Island Capital sees Q2 EPS (34c), consensus 18c 02/24/22 Orchid Island Capital reports Q4 EPS (27c), consensus 23c
Hot Stocks	Plus Therapeutics awarded $17.6M from State of Texas » 17:49 08/17/22 08/17 17:49 08/17/22 17:49 PSTV Plus Therapeutics / + Plus Therapeutics was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events PSTV Plus Therapeutics / + 08/15/22 Plus Therapeutics announces $2M share repurchase program 08/14/22 Plus Therapeutics presents data from Ongoing ReSPECT trials 08/13/22 Plus Therapeutics presents data from Oongoing ReSPECT clinical trials 07/12/22 Plus Therapeutics completes key milestone on path to commercialize 186RNL PSTV Plus Therapeutics / + 07/22/22 H.C. Wainwright Plus Therapeutics price target lowered to $3.50 from $7 at H.C. Wainwright 09/10/22 ESMO Congress 2022
Periodicals	Apollo in talks to acquire minority stake in Manchester United, Daily Mail says » 17:42 08/17/22 08/17 17:42 08/17/22 17:42 APO Apollo Global $59.24 / -1.13 (-1.87%) , MANU Manchester United $13.69 / +0.905 (+7.08%) The Glazer family is in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MANU APO MANU Manchester United $13.69 / +0.905 (+7.08%) 05:48 Today Elon Musk tweets he's buying Manchester United, then calls it a joke 08/04/22 Qualcomm becomes official global partner of Manchester United 07/06/22 DXC Technology, Manchester United enter multiyear technology partnership 07/06/22 Manchester United announces DXC as digital transformation partner APO Apollo Global $59.24 / -1.13 (-1.87%) 08/11/22 Apollo Global closes $2.35B in commitments to Apollo Origination Fund I 08/04/22 Apollo Global, Belstar to form private credit joint venture in Korea 08/04/22 Atlas Air to be acquired by investor group for $5.2B 08/01/22 Apollo Global publishes 13th annual ESG report APO MANU APO Apollo Global $59.24 / -1.13 (-1.87%) 08/12/22 Deutsche Bank Apollo Global price target lowered to $87 from $91 at Deutsche Bank 08/05/22 Deutsche Bank Apollo Global price target raised to $91 from $88 at Deutsche Bank 08/03/22 Stifel Atlas Air downgraded to Hold from Buy at Stifel 08/03/22 Wolfe Research Atlas Air upgraded to Peer Perform from Underperform at Wolfe Research MANU Manchester United $13.69 / +0.905 (+7.08%) 06/02/22 Deutsche Bank Manchester United undervalued after selloff, says Deutsche Bank 03/21/22 Deutsche Bank Manchester United upgraded on 'value disconnect' at Deutsche Bank 03/21/22 Deutsche Bank Manchester United upgraded to Buy from Hold at Deutsche Bank 11/18/21 Deutsche Bank Manchester United price target lowered to $18 from $20 at Deutsche Bank MANU APO MANU Manchester United $13.69 / +0.905 (+7.08%) 05/26/22 Manchester United reports Q3 adjusted EPS (GBP 13.75) vs. (GBP 13.30) last year 03/01/22 Manchester United reports Q2 loss GBP .86 versus 39.17 last year APO Apollo Global $59.24 / -1.13 (-1.87%) 08/04/22 Apollo Global reports Q2 adjusted EPS 94c, consensus $1.02 08/03/22 Notable companies reporting before tomorrow's open 05/05/22 Apollo Global reports Q1 adjusted EPS $1.52, consensus $1.03 06 Oct MANU APO MANU Manchester United $13.69 / +0.905 (+7.08%) 09:34 Today Glazers would consider selling Manchester United stake, Bloomberg reports 08/10/22 Michael Knighton confirms plans to submit bid to buy Manchester United, MEN says APO Apollo Global $59.24 / -1.13 (-1.87%) 08/03/22 Atlas Air near deal to be acquired for $102.50 per share, Bloomberg says 08/01/22 Apollo-led group in late-stage takes to buy Atlas Air, WSJ reports 08/01/22 Apollo-led group in advanced talks to acquire Atlas Air, WSJ reports 07/19/22 Pinco is the sole buyer of EUR 1B of Apollo buyout loans, FT reports MANU APO MANU Manchester United $13.69 / +0.905 (+7.08%) 16:24 Today What You Missed On Wall Street On Wednesday 12:03 Today What You Missed On Wall Street This Morning 08:55 Today Fly Intel: Pre-market Movers APO Apollo Global $59.24 / -1.13 (-1.87%) 08/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/03/22 Fly Intel: Pre-market Movers 08/01/22 What You Missed On Wall Street On Monday 07/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/07/22 Apollo Global Management Inc MANU MANU Manchester United $13.69 / +0.905 (+7.08%) 09:40 Today Unusually active option classes on open August 17th
Hot Stocks	Brooge Energy Ltd trading resumes 17:30 08/17/22 08/17 17:30 08/17/22 17:30 BROG Brooge Energy $7.25 / -0.1 (-1.36%) ShowHide Related Items >><< Company News BROG Brooge Energy $7.25 / -0.1 (-1.36%) 17:02 Today Brooge Energy's majority shareholder expresses interest to take company private 16:55 Today Brooge Energy Ltd trading halted, news pending 05/27/22 Brooge Energy announces receipt of Nasdaq non-compliance letter 03/07/22 Brooge announces decision to add features to select storage tanks
Hot Stocks	Director of Aehr Test Systems Slayen sells over $182K in shares » 17:28 08/17/22 08/17 17:28 08/17/22 17:28 AEHR Aehr Test Systems $16.84 / -0.38 (-2.21%) Director of Aehr Test… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AEHR Aehr Test Systems $16.84 / -0.38 (-2.21%) 07:32 Today Aehr Test Systems receives $4M production order for WaferPak 07/19/22 Aehr Test Systems gets $12.8M in follow-on orders for multiple FOX-XP systems 03/22/22 Aehr Test Systems receives order for WaferPak full wafer contactors 02/23/22 Aehr Test Systems receives order for FOX DiePak Carriers AEHR Aehr Test Systems $16.84 / -0.38 (-2.21%) 10/08/21 Craig-Hallum Aehr Test Systems price target raised to $31 from $12 at Craig-Hallum 08/26/21 Craig-Hallum Aehr Test Systems price target raised to $12 from $5 at Craig-Hallum AEHR Aehr Test Systems $16.84 / -0.38 (-2.21%) 07/19/22 Aehr Test Systems reports Q4 EPS 23c vs. 4c in Q4 last year 06/01/22 Aehr Test Systems completed FY total revenue greater than $50M, one est. $50.56M AEHR Aehr Test Systems $16.84 / -0.38 (-2.21%) 07/19/22 Fly Intel: After-Hours Movers
Earnings	CI&T sees FY22 revenue growth of at least 55% on constant currency basis » 17:25 08/17/22 08/17 17:25 08/17/22 17:25 CINT CI&T $13.90 / +0.12 (+0.87%) On a reported basis, sees… On a reported basis, sees FY22 revenue growth of at least 49%. Sees FY22 adjusted EBITDA margin at least 19%. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options CINT CI&T $13.90 / +0.12 (+0.87%) 08/16/22 CI&T acquires Transpire for $16.4M 06/01/22 CI&T acquires Box 1824, terms undisclosed 05/19/22 CI&T falls -10.9% 05/19/22 CI&T falls -14.6% CINT CI&T $13.90 / +0.12 (+0.87%) 07/20/22 JPMorgan CI&T price target lowered to $15 from $18 at JPMorgan 12/06/21 Fly Intel: Top five analyst initiations 12/06/21 BofA BofA starts 'IT services rare breed' CI&T with a Buy 12/06/21 Morgan Stanley Morgan Stanley starts CI&T at Overweight, sees shares trading at discount CINT CI&T $13.90 / +0.12 (+0.87%) 17:23 Today 3CI&T sees Q3 net revenue up at least 46% from Q322 to R$540M 17:22 Today CI&T reports Q2 up 67% y-o-y to R$525.0M 05/18/22 CI&T raises FY22 net revenue view to $442M from $433M, consensus $431.4M 05/18/22 CI&T sees Q2 net revenue up at least 68% from 1Q21 to R$530M 10 Nov CINT CI&T $13.90 / +0.12 (+0.87%) 05/19/22 Fly Intel: Pre-market Movers 05/18/22 Fly Intel: After-Hours Movers 08/18/22 CI&T - CINT CINT CI&T $13.90 / +0.12 (+0.87%) 05/25/22 new option listings and one option delisting on May 25th
Hot Stocks	Cisco expects continued high levels of order backlog » 17:24 08/17/22 08/17 17:24 08/17/22 17:24 CSCO Cisco $46.69 / -0.09 (-0.19%) Says easing supply chain… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CSCO Cisco $46.69 / -0.09 (-0.19%) 16:46 Today Cisco says cancellations below pre-pandemic levels 16:09 Today Cisco sees Q1 adjusted gross margin 63%-64% 16:08 Today Cisco CEO says full year product orders, backlog at 'record highs' 08/03/22 Fastly names Todd Nightingale as CEO effective September 1 CSCO Cisco $46.69 / -0.09 (-0.19%) 08/15/22 Citi Cisco to trade lower due to valuation multiple compression, says Citi 08/02/22 Citi Arista Networks price target raised to $170 from $160 at Citi 07/15/22 KGI Securities Cisco downgraded to Neutral from Outperform at KGI Securities 07/14/22 JPMorgan Cisco downgraded to Neutral from Overweight at JPMorgan CSCO Cisco $46.69 / -0.09 (-0.19%) 16:07 Today Cisco sees FY23 adjusted EPS $3.49-$3.56, consensus $3.53 16:06 Today Cisco sees Q1 adjusted EPS 82c-84c, consensus 84c 16:05 Today Cisco reports Q4 adjusted EPS 83c, consensus 82c 13:20 Today Notable companies reporting after market close CSCO Cisco $46.69 / -0.09 (-0.19%) 06/23/22 Cisco, Nike planning to fully exit Russia, Reuters reports 06/23/22 Cisco to begin 'orderly wind-down' of Russia business, Reuters reports 06/06/22 CFOs send letter to Treasury Secretary on foreign tax credit rules, WSJ reports CSCO Cisco $46.69 / -0.09 (-0.19%) 12:15 Today Here's what Wall Street experts are saying about Cisco ahead of earnings 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 05/19/22 What You Missed On Wall Street On Thursday 16:30 Today Cisco - CSCO CSCO Cisco $46.69 / -0.09 (-0.19%) 13:04 Today Cisco options imply 4.7% move in share price post-earnings 06/28/22 Cisco put volume heavy and directionally bearish 06/10/22 Cisco put volume heavy and directionally bearish 05/20/22 Notable open interest changes for May 20th
Earnings	3CI&T sees Q3 net revenue up at least 46% from Q322 to R$540M 17:23 08/17/22 08/17 17:23 08/17/22 17:23 CINT CI&T $13.90 / +0.12 (+0.87%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options CINT CI&T $13.90 / +0.12 (+0.87%) 08/16/22 CI&T acquires Transpire for $16.4M 06/01/22 CI&T acquires Box 1824, terms undisclosed 05/19/22 CI&T falls -10.9% 05/19/22 CI&T falls -14.6% CINT CI&T $13.90 / +0.12 (+0.87%) 07/20/22 JPMorgan CI&T price target lowered to $15 from $18 at JPMorgan 12/06/21 Fly Intel: Top five analyst initiations 12/06/21 BofA BofA starts 'IT services rare breed' CI&T with a Buy 12/06/21 Morgan Stanley Morgan Stanley starts CI&T at Overweight, sees shares trading at discount CINT CI&T $13.90 / +0.12 (+0.87%) 17:22 Today CI&T reports Q2 up 67% y-o-y to R$525.0M 05/18/22 CI&T raises FY22 net revenue view to $442M from $433M, consensus $431.4M 05/18/22 CI&T sees Q2 net revenue up at least 68% from 1Q21 to R$530M 05/18/22 CI&T reports Q1 revenue up 66.0% y-o-y to R$491.9M 10 Nov CINT CI&T $13.90 / +0.12 (+0.87%) 05/19/22 Fly Intel: Pre-market Movers 05/18/22 Fly Intel: After-Hours Movers 08/18/22 CI&T - CINT CINT CI&T $13.90 / +0.12 (+0.87%) 05/25/22 new option listings and one option delisting on May 25th
Earnings	CI&T reports Q2 up 67% y-o-y to R$525.0M » 17:22 08/17/22 08/17 17:22 08/17/22 17:22 CINT CI&T $13.90 / +0.12 (+0.87%) Reports Q2 adjusted net… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options CINT CI&T $13.90 / +0.12 (+0.87%) 08/16/22 CI&T acquires Transpire for $16.4M 06/01/22 CI&T acquires Box 1824, terms undisclosed 05/19/22 CI&T falls -10.9% 05/19/22 CI&T falls -14.6% CINT CI&T $13.90 / +0.12 (+0.87%) 07/20/22 JPMorgan CI&T price target lowered to $15 from $18 at JPMorgan 12/06/21 Fly Intel: Top five analyst initiations 12/06/21 BofA BofA starts 'IT services rare breed' CI&T with a Buy 12/06/21 Morgan Stanley Morgan Stanley starts CI&T at Overweight, sees shares trading at discount CINT CI&T $13.90 / +0.12 (+0.87%) 05/18/22 CI&T raises FY22 net revenue view to $442M from $433M, consensus $431.4M 05/18/22 CI&T sees Q2 net revenue up at least 68% from 1Q21 to R$530M 05/18/22 CI&T reports Q1 revenue up 66.0% y-o-y to R$491.9M 03/09/22 CI&T sees 2022 revenue $433M, consensus $408.48M 10 Nov CINT CI&T $13.90 / +0.12 (+0.87%) 05/19/22 Fly Intel: Pre-market Movers 05/18/22 Fly Intel: After-Hours Movers 08/18/22 CI&T - CINT CINT CI&T $13.90 / +0.12 (+0.87%) 05/25/22 new option listings and one option delisting on May 25th
Hot Stocks	Cineworld evaluates strategic options amid slow attendance, limited film slate » 17:20 08/17/22 08/17 17:20 08/17/22 17:20 CNNWF Cineworld Group / + , EPR EPR Properties $51.48 / -3.915 (-7.07%) , CNK Cinemark $17.17 / -0.375 (-2.14%) , AMC AMC Entertainment $21.36 / -3.45 (-13.91%) , IMAX Imax $16.25 / -0.25 (-1.52%) Cineworld Group gave an… Cineworld Group gave an update on trading, liquidity and capital structure earlier on Wednesday. The company said in part: "Cineworld is providing an update today on its current trading, liquidity position and capital structure and the ongoing impact of the COVID-19 pandemic on the Group. Despite a gradual recovery of demand since re-opening in April 2021, recent admission levels have been below expectations. These lower levels of admissions are due to a limited film slate that is anticipated to continue until November 2022 and are expected to negatively impact trading and the Group's liquidity position in the near term. Consequently, the Group has been taking proactive steps to ensure it has the balance sheet strength and flexibility to adapt to market conditions...In connection with these initiatives, the Group remains in active discussions with various stakeholders and is evaluating various strategic options to both obtain additional liquidity and potentially restructure its balance sheet through a comprehensive deleveraging transaction. Any deleveraging transaction will likely result in very significant dilution of existing equity interests in Cineworld...A further announcement will be made if and when appropriate." Other companies that may be impacted include:EPR Properties (EPR ), Cinemark (CNK), AMC Entertainment (AMC) and Imax (IMAX). Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IMAX EPR CNNWF CNK AMC IMAX Imax $16.25 / -0.25 (-1.52%) 08/03/22 Imax and Cineworld expand partnership to 52 Imax locations by 2026 07/11/22 Imax announces $23M debut for 'Thor: Love and Thunder' 06/30/22 Imax extends current share-repurchase program through June 30, 2023 06/13/22 Imax announces $25M global opening for 'Jurassic World: Dominion' EPR EPR Properties $51.48 / -3.915 (-7.07%) 11:56 Today EPR Properties trading resumes 11:36 Today EPR Properties trading halted, news pending 06/02/22 EPR Properties acquires Village Vacances Valcartier for $142M CNNWF Cineworld Group / + 11:45 Today EPR Properties says Regal current on payments, not in negotiations CNK Cinemark $17.17 / -0.375 (-2.14%) 07/01/22 Cinemark says June box office performance 'best in more than two years' 05/25/22 Cinemark founder Lee Roy Mitchell transitions from chairman to board member 02/25/22 Cinemark to open three new theatres, 47 screens during 2022 AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/08/22 AMC Entertainment rises 16.9% 08/08/22 AMC Entertainment trading resumes 08/08/22 AMC Entertainment trading halted, volatility trading pause 08/04/22 AMC CEO says 'could not be more bullish' about improving results CNNWF EPR CNK AMC IMAX CNNWF Cineworld Group / + 03/08/22 JPMorgan Cineworld Group price target lowered to 40 GBp from 81 GBp at JPMorgan 01/11/22 Morgan Stanley Cineworld Group price target lowered to 30 GBp from 50 GBp at Morgan Stanley 12/21/21 Jefferies Cineworld Group downgraded to Hold from Buy at Jefferies 12/16/21 CIBC Cineplex upgraded to Outperformer from Neutral at CIBC EPR EPR Properties $51.48 / -3.915 (-7.07%) 08/15/22 Truist EPR Properties price target raised to $57 from $50 at Truist 07/07/22 Janney Montgomery Scott EPR Properties upgraded to Buy from Neutral at Janney Montgomery Scott 06/21/22 Truist EPR Properties price target lowered to $50 from $51 at Truist 08/20/21 RBC Capital EPR Properties price target raised to $52 from $49 at RBC Capital CNK Cinemark $17.17 / -0.375 (-2.14%) 07/19/22 Morgan Stanley Cinemark upgraded to Overweight from Equal Weight at Morgan Stanley 06/21/22 B. Riley Cinemark price target lowered to $23 from $29 at B. Riley 05/31/22 Benchmark Marcus, Imax, WWE added to entertainment top ideas list at Benchmark 04/13/22 B. Riley Cinemark price target lowered to $29 from $31 at B. Riley AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/16/22 B. Riley B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell 07/07/22 Citi AMC Entertainment price target lowered to $5 from $6 at Citi 06/21/22 B. Riley AMC Entertainment price target lowered to $11 from $16 at B. Riley 06/06/22 Citi AMC Entertainment shares remain overvalued, says Citi IMAX Imax $16.25 / -0.25 (-1.52%) 07/18/22 Benchmark Imax price target lowered to $25 from $28 at Benchmark 06/21/22 B. Riley Imax price target lowered to $25 from $30 at B. Riley 05/23/22 Rosenblatt Imax initiated with a Buy at Rosenblatt IMAX EPR CNK AMC IMAX Imax $16.25 / -0.25 (-1.52%) 07/28/22 Imax reports Q2 adjusted EPS 7c, consensus 15c 04/28/22 Imax reports Q1 adjusted EPS (2c), consensus (5c) 02/23/22 Imax reports Q4 adjusted EPS 31c, consensus 13c EPR EPR Properties $51.48 / -3.915 (-7.07%) 08/01/22 EPR Properties raises FY22 FFOAA view to $4.50-$4.60, consensus $4.77 08/01/22 EPR Properties reports Q2 AFFO $1.23, consensus $1.18 02/22/22 EPR Properties sees FY22 FFOAA/share $4.30-$4.50, consensus $4.19 02/22/22 EPR Properties reports Q4 AFFO/share $1.11, consensus 99c CNK Cinemark $17.17 / -0.375 (-2.14%) 08/05/22 Cinemark reports Q2 EPS (61c), consensus 23c 08/04/22 Notable companies reporting before tomorrow's open 05/06/22 Cinemark reports Q1 EPS (62c), consensus (61c) AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/04/22 AMC Entertainment reports Q2 adjusted EPS (20c), consensus (19c) 05/09/22 AMC Entertainment reports Q1 adjusted EPS (52c), consensus (63c) 05/09/22 Notable companies reporting after market close 05/05/22 Hycroft Mining reports Q1 EPS (27c) vs. (16c) last year CNNWF CNK AMC CNNWF Cineworld Group / + 08/15/22 Summer movies show audiences, studio chiefs committed to theaters, WSJ reports CNK Cinemark $17.17 / -0.375 (-2.14%) 07/11/22 U.S. box office sales rising closer to pre-pandemic levels, CNBC reports AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/13/22 Coinbase looking more like a meme stock, Barron's says IMAX CNNWF CNK AMC IMAX Imax $16.25 / -0.25 (-1.52%) 05/09/22 What You Missed On Wall Street On Monday 05/09/22 What You Missed On Wall Street This Morning 02/23/22 Fly Intel: After-Hours Movers CNNWF Cineworld Group / + 08/15/22 What You Missed On Wall Street This Morning CNK Cinemark $17.17 / -0.375 (-2.14%) 08/05/22 Fly Intel: Pre-market Movers 07/19/22 What You Missed On Wall Street On Tuesday 07/19/22 What You Missed On Wall Street This Morning AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/04/22 Fly Intel: After-Hours Movers 07/15/22 Sell these stocks now, proven algorithm says 09/08/22 Consumer/Media/Entertainment Conference AMC AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/09/22 Notable open interest changes for August 9th 08/08/22 Notable open interest changes for August 8th 08/05/22 Notable open interest changes for August 5th 08/04/22 AMC Entertainment options imply 11.7% move in share price post-earnings

Hot Stocks	Covenant Logistics to sell California terminal for approximately $44M » 17:20 08/17/22 08/17 17:20 08/17/22 17:20 CVLG Covenant Logistics $32.11 / -1.03 (-3.11%) The company has agreed to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CVLG Covenant Logistics $32.11 / -1.03 (-3.11%) 05/24/22 Covenant Logistics announces adoption of $75M Rule 10b5-1 repurchase plan 05/19/22 Covenant Logistics promotes James Grant to CFO 05/19/22 Covenant Logistics announces $75M share repurchase plan, real estate sale CVLG Covenant Logistics $32.11 / -1.03 (-3.11%) 04/14/22 Cowen Covenant Logistics downgraded on trucking weakness at Cowen 04/14/22 Cowen Covenant Logistics downgraded to Market Perform from Outperform at Cowen 04/05/22 Wolfe Research Covenant Logistics price target lowered to $20 from $21 at Wolfe Research 04/01/22 Stephens Stephens downgrades Covenant, Werner ahead of Truckload earnings season CVLG Covenant Logistics $32.11 / -1.03 (-3.11%) 07/25/22 Covenant Logistics reports Q2 adjusted EPS $1.63, consensus $1.28 04/27/22 Covenant Logistics reports Q1 EPS $1.32, consensus 86c
Hot Stocks	Rolls-Royce awarded $1.01B Navy contract » 17:14 08/17/22 08/17 17:14 08/17/22 17:14 RYCEY Rolls-Royce $1.04 / -0.04 (-3.70%) Rolls-Royce was awarded a… Rolls-Royce was awarded a $1.01B firm-fixed-price, indefinite-delivery, requirements contract. This contract provides intermediate, depot-level maintenance and related logistics support for approximately 210 in-service T-45 F405-RR-401 Adour engines in support of the Navy. Work is expected to be completed in July 2027. No funds will be obligated at the time of award; funds will be obligated on individual orders as they are issued. This contract was not competitively procured pursuant to Defense Federal Acquisition Regulation 6.302-1. The Naval Air System Command is the contracting activity. ShowHide Related Items >><< Company News Street Research Periodicals On The Fly RYCEY Rolls-Royce $1.04 / -0.04 (-3.70%) 08/01/22 Rolls-Royce awarded $854.37M Army contract 07/18/22 Rolls-Royce, Hyundai partner on all-electric propulsion, hydrogen fuel cell tech 04/07/22 Infosys and Rolls-Royce launch aerospace innovation center in India 02/24/22 Rolls-Royce announces Warren East to step down as CEO at end of 2022 RYCEY Rolls-Royce $1.04 / -0.04 (-3.70%) 08/05/22 Morgan Stanley Rolls-Royce price target lowered to 110 GBp from 118 GBp at Morgan Stanley 08/05/22 Deutsche Bank Rolls-Royce price target lowered to 90 GBp from 95 GBp at Deutsche Bank 08/05/22 Societe Generale Rolls-Royce price target raised to 92 GBp from 90 GBp at Societe Generale 08/05/22 JPMorgan Rolls-Royce price target lowered to 60 GBp from 70 GBp at JPMorgan RYCEY Rolls-Royce $1.04 / -0.04 (-3.70%) 07/18/22 Rolls-Royce plans to test if hydrogen can power small aircraft, FT reports 07/07/22 Rolls-Royce expects widebody market to rebound faster, Bloomberg says 06/22/22 Rolls-Royce offers GBP2,000 bonus to workers amid inflation woes, WSJ says RYCEY Rolls-Royce $1.04 / -0.04 (-3.70%) 07/08/22 What You Missed On Wall Street This Morning
Hot Stocks	Phillips 66 proposing consideration of $34.75 per unit of DCP Midstream » 17:09 08/17/22 08/17 17:09 08/17/22 17:09 PSX Phillips 66 $89.84 / +1.41 (+1.59%) , DCP DCP Midstream $34.75 / -1.275 (-3.54%) Concurrent with Phillips… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PSX DCP PSX Phillips 66 $89.84 / +1.41 (+1.59%) 17:05 Today Phillips 66 increases interest in DCP Midstream from 28.26% to 43.31% 06/12/22 Fly Intel: Top five weekend stock stories 06/01/22 Phillips 66 VP Herman sells almost $4.9M in company shares 06/01/22 Phillips 66 'taps' FreeWire in support of its 1st U.S. EV charging program DCP DCP Midstream $34.75 / -1.275 (-3.54%) 08/01/22 DCP Midstream releases annual Sustainability Report 07/19/22 DCP Midstream raises Q2 cash distribution 10% to 43c per unit 06/14/22 DCP Midstream enters agreement to acquire Permian Basin for $160M PSX DCP PSX Phillips 66 $89.84 / +1.41 (+1.59%) 07/06/22 Barclays Phillips 66 price target raised to $113 from $95 at Barclays 06/14/22 Wells Fargo Phillips 66 price target raised to $127 from $114 at Wells Fargo 06/13/22 BMO Capital Phillips 66 initiated with an Outperform at BMO Capital 06/13/22 BMO Capital Valero initiated with a Market Perform at BMO Capital DCP DCP Midstream $34.75 / -1.275 (-3.54%) 08/16/22 Barclays DCP Midstream price target raised to $40 from $38 at Barclays 07/20/22 Barclays DCP Midstream price target lowered to $38 from $43 at Barclays 07/12/22 RBC Capital DCP Midstream upgraded to Outperform from Sector Perform at RBC Capital 06/13/22 Raymond James DCP Midstream added to Analyst Current Favorites list at Raymond James PSX DCP PSX Phillips 66 $89.84 / +1.41 (+1.59%) 07/29/22 Phillips 66 reports Q2 adjusted EPS $6.77, consensus $5.78 04/29/22 Phillips 66 reports Q1 adjusted EPS $1.32, consensus $1.22 DCP DCP Midstream $34.75 / -1.275 (-3.54%) 08/02/22 DCP Midstream reports Q2 EPS $1.77, consensus $1.13 05/04/22 DCP Midstream reports Q1 EPS 32c, may not compare to consensus 99c PSX PSX Phillips 66 $89.84 / +1.41 (+1.59%) 06/15/22 Biden calls on oil refiners to boost supply of gas, diesel, CNBC reports 06/11/22 Sunrun, Shell among energy stocks to consider, Barron's says PSX PSX Phillips 66 $89.84 / +1.41 (+1.59%) 06/15/22 What You Missed On Wall Street On Wednesday 08/29/22 Houston & Midland Texas Energy Bus(less) Tour PSX PSX Phillips 66 $89.84 / +1.41 (+1.59%) 06/13/22 Phillips 66 put volume heavy and directionally bearish 04/25/22 Phillips 66 call volume above normal and directionally bullish
Syndicate	QuickLogic files $125M mixed securities shelf 17:06 08/17/22 08/17 17:06 08/17/22 17:06 QUIK QuickLogic $7.64 / -0.46 (-5.68%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly QUIK QuickLogic $7.64 / -0.46 (-5.68%) 06/01/22 QuickLogic awarded new $3.0M eFPGA contract 03/30/22 QuickLogic wins new $1.5M eFPGA contract 03/10/22 QuickLogic wins new eFPGA contract for approximately $1M QUIK QuickLogic $7.64 / -0.46 (-5.68%) 11/18/21 Roth Capital QuickLogic price target raised to $12 from $8 at Roth Capital QUIK QuickLogic $7.64 / -0.46 (-5.68%) 08/16/22 QuickLogic reports Q2 non-GAAP EPS 0c, consensus (4c) 06/01/22 QuickLogic backs Q2 revenue view $4.5M, consensus $4.47M 05/17/22 QuickLogic reports Q1 adjusted EPS (6c), consensus (7c) QUIK QuickLogic $7.64 / -0.46 (-5.68%) 05/17/22 Fly Intel: After-Hours Movers
Syndicate	UMB Financial files automatic mixed securities shelf 17:05 08/17/22 08/17 17:05 08/17/22 17:05 UMBF UMB Financial $98.70 / -0.19 (-0.19%) ShowHide Related Items >><< Street Research Earnings UMBF UMB Financial $98.70 / -0.19 (-0.19%) 04/28/22 Wells Fargo UMB Financial price target lowered to $100 from $110 at Wells Fargo 03/18/22 Raymond James UMB Financial price target raised to $120 from $110 at Raymond James 01/04/22 Wells Fargo Wells Fargo downgrades UMB Financial to Equal Weight, cuts price target to $110 01/04/22 Wells Fargo UMB Financial downgraded to Equal Weight from Overweight at Wells Fargo UMBF UMB Financial $98.70 / -0.19 (-0.19%) 07/26/22 UMB Financial reports Q2 EPS $2.83, consensus $1.90 04/26/22 UMB Financial reports Q1 adjusted EPS $2.17, consensus $1.67

Events

Earnings calls, analyst events, roadshows and more

OCFT
Today at 20:00

OneConnect - OCFT Conference Calls
ZTO
Today at 20:30

ZTO Express - ZTO Conference Calls
BEST
Today at 21:00

Best Inc. - BEST Conference Calls
REGI ...
Tomorrow at 00:00

Energy Leaders Transition Summit Conferences

Aspen, CO
RNST ...
Tomorrow at 00:00

Atlanta Bank Summit Conferences

Virtual Summit
MATW ...
Tomorrow at 00:00

August Virtual Micro Cap Conference Conferences

Virtual Conference
Tomorrow at 00:00

Western Bank Summit Conferences

Los Angeles, CA
Tomorrow at 00:00

Vaccine Virtual Forum Conferences

Virtual Forum
Tomorrow at 00:00

Summer Workshop on Money, Banking, Payments & Finance Conferences

Washington, D.C.
Tomorrow at 00:00

4th Annual Virtual FinTech & Digital Transformation Conference Conferences

Virtual Conference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BROS X BROS Dutch Bros Block Trade Managers: Morgan Stanley Priced at: $43.50 5.97M Shares GRFX X GRFX Graphex Group IPO Managers: EF Hutton Priced at: $2.50 4.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LUCY X LUCY Innovative Eyewear IPO Managers: Maxim Priced at: $7.50 980K Shares SVFD X SVFD Save Foods Secondary Managers: ThinkEquity Priced at: $3.00 1.6M Shares FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: Goldman Sachs & SVB Securities, Stifel, Oppenheimer Priced at: $7.82 9.591M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TELA X TELA Tela Bio Spot Secondary Managers: Lake Street Priced at: $8.00 4M Shares TRIN X TRIN Trinity Capital Spot Secondary Managers: Keefe Bruyette, Morgan Stanley, UBS & Wells Fargo Priced at: $15.33 3.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	BE X BE Bloom Energy Secondary Managers: JPMorgan, Morgan Stanley & BofA Priced at: $26.00 13M Shares VRDN X VRDN Viridian Therapeutics Secondary Managers: Jefferies, SVB Securities & Evercore ISI Priced at: $23.50 9.628M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLE X ASLE AerSale Spot Secondary Managers: Cowen, RBC Capital & Stifel, Truist Priced at: $17.25 4.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OPCH X OPCH Option Care Health Spot Secondary Managers: Goldman Sachs Priced at: $33.25 11M Shares OSH X OSH Oak Street Health Spot Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley, William Blair & Piper Sandler Priced at: $25.75 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	GFRX X GFRX Graphex Group Secondary Managers: EF Hutton Priced at: $2.50 4.7M Shares
Thurs	No deals
Fri	No deals

Mon	DVAX X DVAX Dynavax Block Trade Managers: Goldman Sachs $14.85-15.62 3M Shares
Tues	No deals
Wed	UBX X UBX Unity Biotechnology Secondary Managers: SVB Securities, Cantor Fitzgerald & MIZU, Wedbush $1.37 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

PDS Biotechnology announces presentation of Phase 2 data on PDS0101 at ASCO

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access